Content
Frontiers of Medicine >> 2023, Volume 17, Issue 2 doi: 10.1007/s11684-022-0956-8
Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
Abstract
Keywords
benzydamine ; cyclin-dependent kinase 2 ; patient-derived xenograft ; esophageal squamous cell carcinoma
Content